Moretto R, Rossini D, Polito MG, Antoniotti C, et al. The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies. Eur J Cancer 2025;222:115470.
PMID: 40306121